NONO::TFE3 fusion cutaneous epithelioid and spindle cell tumor: A case series
Journal of Cutaneous Pathology · 2023
DOI: 10.1111/cup.14518 ↗At a glance
Fallbericht in Journal of Cutaneous Pathology, 2023. Written by Sharlene Helene C See and 6 co-authors. Institution: Department of Dermatology, Section of Dermatopathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. Major MEDLINE topics: Carcinoma, Renal Cell, Perivascular Epithelioid Cell Neoplasms, Skin Neoplasms, Kidney Neoplasms. Cited 4 times so far (Crossref); 26 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
The NONO::TFE3 fusion has been described in MiT family translocation renal cell carcinomas as well as extracutaneous perivascular epithelioid cell tumors (PEComas). PEComas are known to express myogenic and melanocytic markers but SOX10 and p63 positivity has never been reported. We report two primary cutaneous tumors that morphologically and molecularly fit PEComas, both harboring the NONO::TFE3 fusion, but with an unusual immunophenotype of SOX10 and p63 positivity. One case was on an 80‐year‐old male's finger, and the other one was on a 72‐year‐old female's thigh. Both were well‐circumscribed multinodular dermal tumors composed of nests of monotonous epithelioid to spindled cells with pale to vacuolated cytoplasm, some of which were arranged around blood vessels. Both tumors were positive for SOX10, S100, and p63, focally positive for Melan‐A, and negative for myogenic markers. There are very little data regarding the molecular findings of primary cutaneous PEComas. While the NONO::TFE3 fusion has been identified in extracutaneous PEComas, it has never been reported in primary cutaneous cases. We believe these cases represent a previously undescribed subtype of cutaneous tumor which shows some immunophenotypic expression of melanocytic markers and we named these cases NONO::TFE3 fusion cutaneous epithelioid and spindle cell tumor. Further, we raise the question of whether this tumor should fall under the rubric of PEComa because of its morphology, partial expression of melanocytic markers, and the presence of the NONO::TFE3 fusion, or whether these tumors represent a separate novel class of tumors since the immunophenotypic expression of SOX10 and p63 is unusual for PEComas.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Dermatology, Section of Dermatopathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
- Wright State University Boonshoft School of Medicine, Dayton, Ohio, USA.
ORCID profiles: Sharlene Helene C See
Cite
APA
See, S. H. C., Olivares, S., Kulkarni, M., Dhillon, S. K., Fumero-Velazquez, M. S., Hagstrom, M. N. E., & Gerami, P. (2023). NONO::TFE3 fusion cutaneous epithelioid and spindle cell tumor: A case series. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.14518
Vancouver
See SHC, Olivares S, Kulkarni M, Dhillon SK, Fumero-Velazquez MS, Hagstrom MNE, et al. NONO::TFE3 fusion cutaneous epithelioid and spindle cell tumor: A case series. Journal of Cutaneous Pathology. 2023. doi:10.1111/cup.14518
BibTeX
@article{See2023,
author = {See, Sharlene Helene C and Olivares, Shantel and Kulkarni, Maansi and Dhillon, Soneet K and Fumero-Velazquez, Monica Stella and Hagstrom, Michael Norman E and Gerami, Pedram},
title = {NONO::TFE3 fusion cutaneous epithelioid and spindle cell tumor: A case series},
journal = {Journal of Cutaneous Pathology},
year = {2023},
doi = {10.1111/cup.14518}
}
EUVIMED